About
Titles
Hospital Resident
Education & Training
- MD
- SUNY Downstate Medical Center College of Medicine (2020)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Tashzna Jones's published research.
Dinesh Singh, MD
Mursal Gardezi, MD
Preston C. Sprenkle, MD
Publications
2023
MP59-12 CAN ANATOMICAL MEASUREMENTS ON PREOPERATIVE PELVIC MAGNETIC RESONANCE IMAGING PREDICT POSTOPERATIVE URINARY INCONTINENCE AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE?
Khan A, Choksi A, Rahman S, Press B, Jalfon M, Gardezi M, Jones T, Hayden C, Ghiraldi E, Siev M, Lacy G, Sprenkle P, Kellner D. MP59-12 CAN ANATOMICAL MEASUREMENTS ON PREOPERATIVE PELVIC MAGNETIC RESONANCE IMAGING PREDICT POSTOPERATIVE URINARY INCONTINENCE AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE? Journal Of Urology 2023, 209: e812. DOI: 10.1097/ju.0000000000003312.12.Peer-Reviewed Original Research
2022
Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States
Laditi F, Nie J, Jones T, Leapman MS. Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States. European Urology Focus 2022, 8: 910-912. PMID: 35778364, DOI: 10.1016/j.euf.2022.06.003.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsProstate magnetic resonance imagingMagnetic resonance imagingWhite patientsMagnetic resonance imaging (MRI) scansRisk stratification toolLarge observational studiesResonance imaging scansGene expression testStratification toolImaging scansCancer toolProstate cancerObservational studyPractice variationModifiable sourceResonance imagingGenetic testingPatientsRacial variationGenomic testingUS studiesLow useLess useExpression testReviewAssociation Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC. Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer. European Urology Open Science 2022, 37: 113-119. PMID: 35243396, PMCID: PMC8883188, DOI: 10.1016/j.euros.2022.01.008.Peer-Reviewed Original ResearchCitationsAltmetricConceptsDecipher scoreMultivariable logistic regressionGleason grade groupActive surveillanceProstate cancerBiopsy GleasonBiopsy upgradingGG2 diseaseGenomic classifierFavorable intermediate-risk prostate cancerBiopsy Gleason grade groupIntermediate-risk prostate cancerLogistic regressionDecipher genomic classifierHigher Decipher scoresRetrospective cohort studyBaseline clinical variablesHigh-grade diseaseBiopsy reclassificationDecipher testDecipher testingGleason upgradeCohort studyMedian ageClinical variables
2021
NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing
Seiden B, Weng S, Sun N, Gordon D, Harris W, Barnett J, Myrie A, Jones T, Pak S, Fudl A, Shields J, McNeil B, Weiss J, Smith M, Esdaille A, Winer A. NCCN Risk Reclassification in Black Men with Low and Intermediate Risk Prostate Cancer After Genomic Testing. Urology 2021, 163: 81-89. PMID: 34688772, DOI: 10.1016/j.urology.2021.08.055.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsNCCN riskIntermediate riskGenomic testingLower riskPre-biopsy prostate specific antigenNational Comprehensive Cancer Network guidelinesIntermediate-risk prostate cancerFavorable intermediate riskNCCN risk classificationPre-biopsy PSARisk classificationRisk prostate cancerUnfavorable intermediate riskProstate-specific antigenInitial risk classificationMedian ageBlack patientsNetwork guidelinesActive surveillanceProstate cancerHigher oddsSpecific antigenNonparametric statistical testingPatientsRiskRacial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database
Wolff D, Monaghan T, Gordon D, Michelson K, Jones T, Khargi R, Smith M, Maffucci F, Kwun H, Suss N, Winer A. Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database. Medicina 2021, 57: 671. PMID: 34209546, PMCID: PMC8303448, DOI: 10.3390/medicina57070671.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsNational Cancer DatabaseGenitourinary cancersBladder cancerCancer DatabaseProstate cancerCancer casesKidney cancerPrimary tumor locationPatient demographic factorsNew cancer diagnosesCoverage ratePenile cancerBlack patientsGenitourinary malignanciesTesticular cancerTumor locationMajor cancersHealth equity researchCancerWhite subjectsCancer diagnosisLow coverage rateWhite femalesRacial differencesEndourological management of a rare radiopaque ritonavir-composed urinary calculus
Laditi F, Khan A, Ghiraldi E, Jones T, Choksi A, Singh D. Endourological management of a rare radiopaque ritonavir-composed urinary calculus. Urology Case Reports 2021, 39: 101763. PMID: 34295648, PMCID: PMC8281602, DOI: 10.1016/j.eucr.2021.101763.Peer-Reviewed Original ResearchAltmetricConceptsProtease inhibitorsCertain protease inhibitorsClinic complainingFlank painGross hematuriaSurgical removalEndourological managementUreteral stonesCT scanRitonavirUrinary stonesUrinary calculiUrinary stone componentsStone componentsInhibitorsFirst reportStonesHematuriaPainHIVAtazanavirPatientsNephrolithiasisComplaining